OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Home Antibody All anti-MAGEB1 antibodies

Anti-MAGEB1 DETECTION Antibody Clone 3B7


Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
  • Luminex validated biotinylated MAGEB1 mouse monoclonal antibody (clone 3B7), detection
50ug $345 3 Weeks
Matched Antibody
  • Luminex validated MAGEB1 mouse monoclonal antibody (clone 5G7), capture, 100 ug
TA600357 $325 2 Weeks Add to Shopping Cart
Add to Shopping Cart
Also for MAGEB1 (NM_002363)
cDNA Clone shRNA/siRNA CRISPR KO Kit Protein Antibody

OriGene Data

ImmunogenFull length human recombinant protein of human MAGEB1 (NM_002363) produced in HEK293T cell.
Clone NameClone 3B7 IsotypeIgG1
Species ReactivityHuman Concentration0.5 mg/ml
Guaranteed Application *LMNX Suggested DilutionsLMNX
BufferStored in PBS (pH 7.4) with 0.05% sodium azide, 10mg/ml BSA, 50% glycerol

Reference Data

Target NameHomo sapiens melanoma antigen family B, 1 (MAGEB1), transcript variant 1
Alternative NameCT3.1; DAM10; MAGE-Xp; MAGEL1
Database LinkNP_002354
Entrez Gene 4112 Human
Related Pathway

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

LMNX Image
MAGEB1 Luminex Elisa with 5G7 Capture (TA600357) and 3B7 Detection (TA700357) Antibodies. Substrate used: Recombinant Human MAGEB1 (LY419376)


Inc 5000 Healthcare Company Copyright © 2015 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title